Narrow these 4 — tap a value to filter:
Trait 2
Open an event to see its evidence. Attack and trait tags link to their definitions
May 29, 2026 Trump signed executive order directing CDC to cut recommended childhood vaccines nearly in half Tier 1 · Primary Power and Authority
A presidential order redirected federal public-health policy on childhood immunization based on an ideologically driven assessment, prompting lawsuits from fifteen states.
Supporting reports
- Trump signs executive order realigning U.S. childhood vaccine schedule with peer nations' recommendations — President Trump signed Executive Order 14407 directing the CDC and its Advisory Committee on Immunization Practices to review a scientific assessment comparing U.S. childhood immunization recommendations with peer developed nations and update the vaccine schedule accordingly. The order acknowledges that the U.S. currently recommends more childhood vaccines than peer nations and directs federal agencies to align immunization policies with the updated schedule while preserving parental authority and religious freedom protections. All vaccines on the revised schedule remain covered without cost-sharing by insurance and public programs.
- Trump executive order directs CDC to halve childhood vaccine recommendations — Donald Trump signed an executive order on May 29, 2026, instructing the Centers for Disease Control and Prevention to reduce the number of recommended childhood vaccines by nearly half, based on a health department assessment authored by anti-vaccine activist Robert F. Kennedy Jr.'s HHS. The order would remove vaccines for hepatitis A, hepatitis B, meningitis, rotavirus, influenza, and COVID-19 from the recommended schedule, and cut HPV vaccine doses. Fifteen Democratic-led states have sued to block the changes, arguing they lack scientific basis and will increase disease outbreaks and childhood illness.
- Trump issues executive order realigning U.S. childhood vaccine schedule with peer nations' recommendations — President Trump issued an executive order on May 29, 2026, directing the Department of Health and Human Services to realign U.S. childhood vaccine recommendations with those of peer developed nations. The order cites a scientific assessment finding that the U.S. recommends more childhood vaccines than comparable countries and directs the CDC and its Advisory Committee on Immunization Practices to review and update the vaccine schedule accordingly. The order emphasizes parental authority, religious freedom protections, and maintaining vaccine access through insurance and public programs while reducing the number of recommended doses.
- White House issues fact sheet on executive order realigning childhood vaccine schedule — The White House published a fact sheet on May 29, 2026, describing an executive order signed by President Trump directing the CDC and its Advisory Committee on Immunization Practices (ACIP) to review an HHS scientific assessment comparing U.S. childhood vaccine recommendations with those of peer developed nations. The order directs ACIP to update the U.S. childhood vaccine schedule based on this review, emphasizing flexibility for parents and doctors. The fact sheet states the assessment found the U.S. recommends more childhood vaccines than peer nations and recommends prioritizing 11 routine vaccines while preserving individualized decision-making.
- White House signed executive order realigning U.S. childhood vaccine schedule with peer nations' recommendations — The White House signed Executive Order 14407 directing the CDC and its Advisory Committee on Immunization Practices to review and update the U.S. childhood vaccine schedule based on a scientific assessment comparing American recommendations with those of peer developed nations. The order states the assessment found the U.S. recommends more childhood vaccines than peer countries, including twice as many doses as some European nations, and identifies a consensus set of vaccines recommended across all peer countries. The order directs federal agencies to align immunization policies, funding, and coverage with the updated CDC schedule while preserving parental authority and religious freedom protections.
May 27, 2026 Trump administration barred NIAID officials from communicating with WHO during active disease outbreaks Corroborated Information, Memory and Manipulation
Restrictions on public-health officials' international communications during Ebola and hantavirus outbreaks prioritized political withdrawal over disease-surveillance cooperation.
Supporting reports
- Trump administration barred NIAID officials from WHO communications — The Trump administration barred key U.S. officials from the National Institute of Allergy and Infectious Diseases from communicating with officials at the World Health Organization, from which Trump had withdrawn the United States. The restriction was slightly relaxed following the outbreak of hantavirus on a cruise ship with U.S. passengers and a breaking Ebola epidemic in the Democratic Republic of Congo, allowing U.S. officials to attend small virtual meetings only "in a listening capacity."
May 26, 2026 Marty Makary reportedly resigned as FDA Commissioner after being directed to reverse flavored-vape ban Tier 1 · Primary Economic Structure
A senior health regulator resigned in protest over presidential pressure to weaken child-protective nicotine rules after industry lobbying, exposing politicization of public-health policy.
Supporting reports
- FDA Commissioner Marty Makary resigns over flavored vape reversal — FDA Commissioner Marty Makary reportedly resigned in protest after Trump directed him to reverse the FDA's prohibition on fruit-flavored vapes. The reversal occurred within a week of Trump's meeting with Reynolds American executives and lobbyist Brian Ballard, who had complained about the ban. The fruit-flavored vape ban had been implemented to protect children from the appeal of flavored nicotine products.
May 23, 2026 Trump FDA issued guidance permitting flavored vape sales after a $5 million tobacco donation to Trump's super PAC Tier 1 · Primary Economic Structure
A regulatory reversal followed a large corporate donation to a presidential political fund, illustrating pay-to-play dynamics in federal rulemaking.
Supporting reports
- FDA issues guidance opening door to flavored vape sales after tobacco donation — The Trump Food and Drug Administration issued new guidance opening the door to the sale of flavored vapes after a tobacco company donated $5 million to the Trump-backed super PAC MAGA Inc. Two days after the donation, Trump had lunch with tobacco industry representatives, during which he complained to administration officials about FDA e-cigarette regulations. The new guidance was issued days later.